Current challenges in chronic graft-versus-host disease

Area of Science:

• Hematology
• Immunology
• Transplantation Medicine

Background:

• Chronic graft-versus-host disease (cGVHD) is a significant complication following hematopoietic stem cell transplantation (HSCT).
• It is the primary cause of late nonrelapse mortality (NRM) after HSCT.
• Current management faces challenges due to a lack of validated diagnostic and severity criteria, and unpredictable treatment responses.

Purpose of the Study:

• To review recent advancements in addressing critical unresolved areas of cGVHD.
• Focus on progress in diagnostic criteria, severity assessment, and treatment predictability.

Main Methods:

• Literature review of recent scientific publications.
• Analysis of studies focusing on diagnostic tools, severity scoring systems, and therapeutic strategies for cGVHD.

Main Results:

• Recent progress has been made in developing more reliable diagnostic and severity criteria for cGVHD.
• Understanding of human pathophysiology is improving, aiding in targeted treatment development.
• Advances in treatment strategies show potential for more predictable clinical responses.

Conclusions:

• Significant strides have been made in improving the diagnosis and severity assessment of cGVHD.
• Ongoing research is enhancing the predictability of clinical responses to first-line treatments.
• These advancements are crucial for improving outcomes for HSCT recipients experiencing cGVHD.